340B Drug Discount Program

The 340B prescription drug program supports critical health services in our communities. Savings from the 340B program help hospitals meet the healthcare needs of underserved patients across the country. Premier Health’s Miami Valley Hospital and Atrium Medical Center both qualify for the 340B program and collectively saved $69.9 million and $54.0 million in 2025 and 2024, respectively. 340B savings assist health systems in partially subsidizing services to patients that operate at a loss.

Premier Health’s Commitment to the Community

Consistent with Premier Health’s mission, care is provided to patients regardless of their ability to pay. For patients who qualify as charity care based on their inability to pay, the estimated cost incurred by Premier Health to provide services, less recognized charity care subsidies, was $31.5 million and $22.7 million for 2025 and 2024, respectively. Also consistent with Premier Health’s mission, services are provided to Medicare and Medicaid covered patients where payment is not sufficient to cover the cost of providing the service. The shortfall of payment to cost in unreimbursed Medicaid, Medicare, and other means-tested government programs totaled $395.0 million and $449.8 million in 2025 and 2024, respectively. Premier Health has also provided other community health improvement, community benefit, and subsidized health services totaling $45.3 million and $86.1 million in 2025 and 2024, respectively.

The 340B Program’s Critical Role

The savings from the 340B program play a critical role in ensuring access to many health services to patients regardless of their ability to pay, and the savings only cover a small portion of the overall unfunded and underfunded care provided across all patients.